HIV gp120-NefTat/AS01B vaccine

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIV gp120-NefTat/AS01B vaccine, covering 2019-11-18 to 2019-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461) [Phase 1]